P3.01-85 Real-World Gefitinib 1st line treatment  of patients with advanced NSCLC and EGFR mutations - Serbian single center experience

Radosavljević, Davorin Z.; Spasić, Jelena; Ristić Marija; Nikolić, Vladimir; Nikolic, Neda; Stanić, Nemanja; Đorđević, Feđa; Gavrilović Dušica

Rezultati

eNauka > Results > P3.01-85 Real-World Gefitinib 1st line treatment of patients with advanced NSCLC and EGFR mutations - Serbian single center experience

Title:	P3.01-85 Real-World Gefitinib 1st line treatment of patients with advanced NSCLC and EGFR mutations - Serbian single center experience
Authors:	Radosavljević, Davorin Z. ; Spasić, Jelena ; Ristić Marija; Nikolić, Vladimir; Nikolic, Neda ; Stanić, Nemanja; Đorđević, Feđa; Gavrilović Dušica
Issue Date:	2018
Publication:	IASLC. 19TH WORLD CONFERENCE ON LUNG CANCER. WCLC 2018
Publisher:	IASLC 19. www.IASLC.org. Abstracts. Poster Session
Type:	Conference Paper
Collation:	vol. 13 br. 10 str. 657 P3.01-85-658
URI:	https://enauka.gov.rs/handle/123456789/356719
URL:	https://s3.amazonaws.com/iaslc/pdf/WCLC2018-Abstract-Book_Web.pdf
Metadata source:	Migrirano iz RIS podataka
M-category:	Mp. category will be shown later

Find the DOI

Finding a DOI in CrossRef based on publication meta-data. The DOI (and metadata) with the similar data match will be displayed. ATTENTION - it doesn't have to be that publication.

Google Scholar^TM